Review decisions

Showing 110 results of 283 total
Summary Safety Review - Oral prednisone and prednisolone (glucocorticoids) - Assessing the potential risk of a serious complication called scleroderma renal crisis in patients with systemic sclerosis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00208
Issued / Original Publication Date: 2018-08-07
Summary Safety Review - METHADOSE and METADOL-D - Assessing the potential risk of serious harm in children exposed to methadone through breast milk
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00207
Issued / Original Publication Date: 2018-08-03
Summary Safety Review - IMBRUVICA (ibrutinib) - Assessing the potential risk of a serious and life-threatening abnormal heart rhythm (ventricular tachyarrhythmia)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00206
Issued / Original Publication Date: 2018-07-26
Summary Safety Review - REMICADE (infliximab) - Assessing the potential risk of a blistering skin condition known as linear IgA bullous dermatosis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00205
Issued / Original Publication Date: 2018-07-23
Summary Safety Review - Sodium/glucose cotransporter 2 (SGLT2) inhibitors - Assessing the potential risk of inflammation of the pancreas (acute and chronic pancreatitis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00204
Issued / Original Publication Date: 2018-07-20
Summary Safety Review - Imatinib mesylate (GLEEVEC and generics) - Assessing the potential risk of tendon disorders
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00202
Issued / Original Publication Date: 2018-06-08
Summary Safety Review - Enterra Therapy System - Assessing the potential lack of effect
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00203
Issued / Original Publication Date: 2018-05-25
Updated Date: 2018-06-08
Summary Safety Review - Isoniazid - Assessing the potential risk of inflammation of the pancreas (pancreatitis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00201
Issued / Original Publication Date: 2018-05-10
Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00196
Issued / Original Publication Date: 2018-05-07
Summary Safety Review - Gadolinium based contrast agents - Assessing the risk of gadolinium build-up in the brain and potential brain and nervous system (neurological) side effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00200
Issued / Original Publication Date: 2018-05-01

Displaying 101 - 110 of 283 | Page 11 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: